Xtandi 80 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJQC7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,422
Award facts
- Contract value 100% obligated
- $4,422.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,422.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count units). This firm fixed-price delivery order, issued on February 4, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, indicating the award was made through full and open competition. The contract represents a routine pharmaceutical supply transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense military healthcare facilities worldwide. As a regional prime vendor contractor, DMS Pharmaceutical Group supplies branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring DoD medical supply requirements. The company's establishment as a prime vendor contractor and demonstrated performance across numerous delivery orders reflects its capability to fulfill the specialized and diverse pharmaceutical needs of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FJQC7?
SPE2DR26FJQC7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FJQC7 worth?
The government has obligated $4,422 on SPE2DR26FJQC7.
Is contract SPE2DR26FJQC7 an order under another contract?
Yes. SPE2DR26FJQC7 is a delivery order under SPE2DR25D9224, an indefinite delivery contract.
Was contract SPE2DR26FJQC7 competed?
The extent of competition for SPE2DR26FJQC7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award